United States· US:68083-412_706b6332-5afe-498b-a846-788e6ebc6823
Cangrelor
A cangrelor product containing cangrelor, registered in United States by Gland Pharma Limited. The same ATC class is registered in 13 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Cangrelor is registered in 13 of 19 countries.
Countries holding a registration under ATC B01AC25 (cangrelor), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 9 of them publish a price we can compare per daily dose
Cangrelor · ATC B01AC25
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- CANGRELOR
- Manufacturer
- Gland Pharma Limited
- Country
- United States (US)
- ATC code
- B01AC25
- ATC class
- Cangrelor
- Defined daily dose
- 50 mg, P
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1168083-412-10
- ndc11680834121010 VIAL, SINGLE-DOSE in 1 CARTON (68083-412-10) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
135 interactions on record for cangrelor.
Graded by severity as the source publishes them — 65 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Cangrelor · interactions on record
135 records
- 65 severe
- 70 moderate
Most severe, free to view
- DicoumarolB01AA01severe
- WarfarinB01AA03severe
- HeparinB01AB01severe
- Antithrombin IIIB01AB02severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Cangrelor in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomKengrexal 50mg powder for concentrate for solution for injection / infusion vialsChiesi Ltd
- SwitzerlandKengrexal 50mg, poudre pour solution à diluer pour solution injectable/pour perfusionChiesi SA
- CzechiaKENGREXALChiesi Farmaceutici S.p.A., Parma
- SpainKENGREXAL 50 MG POLVO PARA CONCENTRADO PARA SOLUCION INYECTABLE Y PARA PERFUSIONChiesi Farmaceutici S.P.A.
- FranceKENGREXAL 50 mg, poudre pour solution à diluer pour solution injectable/pour perfusionCHIESI FARMACEUTICI
- IcelandKengrexalChiesi Farmaceutici S.p.A.*
- NetherlandsKengrexal 50 mg poeder voor concentraat voor oplossing voor injectie / infusieChiesi Farmaceutici S.p.A.
- PolandKengrexalChiesi Farmaceutici S.p.A.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/12c1af6c-ba4d-4708-9e8f-a4ede89d16c7 GET /v1/drugs/12c1af6c-ba4d-4708-9e8f-a4ede89d16c7?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRAVENOUS",
"source": "ndc",
"strength": "50",
"substance": "CANGRELOR",
"productndc": "68083-412",
"dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "ANDA213551",
"marketing_category": "ANDA"
}See everything about cangrelor.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.